Géraldine Lautrette

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Katrina Moore, Jennifer Nicholas, Murray Grossman et al. · The Lancet Neurology · 2019 · 311 citations · Full text

Medicine, Genetics, Neurology +17

Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis

Pierre Jésus, P. Fayemendy, Marie Nicol et al. · European Journal of Neurology · 2017 · 101 citations

Agriculture, Neurology, Nutrition +17

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 85 citations · Full text

Life Sciences, Neurology, Neuroscience +10

Population‐based epidemiology of amyotrophic lateral sclerosis (<scp>ALS</scp>) in an ageing<scp>E</scp>urope – the<scp>F</scp>rench register of<scp>ALS</scp>in<scp>L</scp>imousin (<scp>FRAL</scp>im register)

Benôıt Marin, Bello Hamidou, Philippe Couratier et al. · European Journal of Neurology · 2014 · 65 citations

Medicine, Neurology, Neuroscience +12

Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis

Elisa Teyssou, Laura Chartier, Maria del Mar Amador et al. · Neurobiology of Aging · 2017 · 63 citations · Full text

Life Sciences, Neurology, Neuroscience +16